Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
about
Pregabalin for acute and chronic pain in adultsEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiPharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialThe effectiveness of anticonvulsants in psychiatric disordersGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Enigma of painful diabetic neuropathy: can we use the basic science, research outcomes and real-world data to help improve patient care and outcomes?Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.Treatment of diabetic sensory polyneuropathy.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Diabetic neuropathy: mechanisms to managementThe management of diabetic neuropathy in CKD.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesA cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationPatient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Neuromuscular diseases associated with HIV-1 infection.Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Diabetic neuropathy: clinical manifestations and current treatments.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Treatment of painful diabetic neuropathyEFNS guidelines on pharmacological treatment of neuropathic pain.Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetineDiabetic neuropathy: new strategies for treatment.Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefA comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.Sensory pain qualities in neuropathic painPredictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials.Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy.Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic reviewMorphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.
P2860
Q24239867-8BC52C69-E9E9-4CF1-9511-1DC7E57A4082Q24632313-48FF5E68-313F-45F4-9909-08A1C5314C10Q24657295-F582516F-F00A-43A7-9D67-AB9591AA3B13Q26781422-A1A4DB9C-15B6-4193-8B41-50388C909F2FQ28744504-F512603A-6984-4838-88D8-D0387623ED01Q30537158-DB542C8B-8614-4C25-9147-2ECC04377E18Q31043237-067C83AB-58EB-4F56-8135-CD8DAB3F639DQ31170335-2EC093BC-2F0F-4287-A721-9D0B6FB8FD52Q33369978-A03A25B5-6FE1-44FB-B401-16F0E4CE7AFDQ33393882-935127A4-5F7E-4A12-9ED1-8F8E8F4F027BQ33408025-DD7512D8-5885-492F-87EC-675EE0E68999Q33554384-817B05BF-95F4-4C04-B94E-5111559AF553Q33554396-27F50D5C-68C1-4F59-9487-212927827E33Q33583006-4FFBFA88-25F3-4807-9979-81EA9D779113Q33585572-6028A98B-29F8-42B2-B583-D3D612C164FDQ33628834-55C2B5E0-696A-4FAD-A019-15EB5C76757CQ33739953-55F5C77A-C35D-4A44-B494-B8D21A1A0DB2Q33798640-BA9C5A5A-7B67-4024-8589-9CF5E59A0A72Q33870062-08BC888B-5FBA-4FA5-AA46-5B3A6762E5B6Q33880187-05FFB2FB-9E10-4312-8314-48E7F3BCB28CQ33921692-9D1397D9-56C0-4B6D-AE11-7E474C64BAD4Q33949565-5D4D2774-277C-4A5A-BD5E-730FEA56E63AQ34047113-C607F014-8E8D-48F2-A73F-CC04BDC87149Q34134958-8DDFBE26-AF46-48EA-9FD2-E540C5690005Q34183517-DC0C8E5B-0B5D-4D3C-8FF0-38844EE7FCCCQ34275990-9E7AA506-E264-4FC7-981D-8063E5DC77EFQ34411257-20079678-E7A7-49C1-91BA-86095A802E4CQ34456265-08D09E6C-A635-493D-84C7-F66789759D52Q34573607-D664EF49-4524-4C23-AE09-E7986D97E605Q34620539-6B61BF15-F814-4FFF-BCEA-F6B7AC24D3F2Q34641965-9E4A11D8-6809-43D5-B325-CCEC86240579Q34756216-3A9D8579-E480-4E48-A9C8-AC9117D484BFQ35061149-DED6AB4D-C6B5-4074-8C9D-AE5525214750Q35080568-6540AA76-FE53-49E9-A7DB-B23BA6CEFD05Q35576767-6BB5924F-D534-4036-88C0-643004E88AFDQ35645285-E24D537B-0F8F-46BD-AEB9-B1B692CF0225Q35694450-AF1E334C-F3D4-493A-B1CA-39C20E9F584CQ35732613-7A82C3DA-96B0-4E4F-84B1-F62B89CD60E4Q35955249-C2C438E3-AF3B-4B49-B717-B9C97417EB1DQ35987634-96489DF7-47DF-46A9-978B-B955E06B79D4
P2860
Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@en
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@nl
type
label
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@en
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@nl
prefLabel
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@en
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@nl
P2093
P1433
P1476
Relief of painful diabetic per ...... zed, placebo-controlled trial.
@en
P2093
Howard Bockbrader
Linda Lamoreaux
Lloyd E Knapp
Ralph W Richter
Russell Portenoy
Uma Sharma
P304
P356
10.1016/J.JPAIN.2004.12.007
P577
2005-04-01T00:00:00Z